08:00 , Dec 6, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Non-small cell lung cancer (NSCLC) Transforming growth factor-b receptor II (TGFb-RII; TGFBR2); mediator complex subunit 12 (MED12) In vitro studies suggest inhibiting TGFBR2 could help...